Aliases & Classifications for Osteoporosis

MalaCards integrated aliases for Osteoporosis:

Name: Osteoporosis 54 38 12 24 71 52 41 42 14 69
Osteoporosis, Postmenopausal 54 42 69
Postmenopausal Osteoporosis 71 29
Osteoporosis, Involutional 54 13
Bone Mineral Density Variation Qtl, Osteoporosis 54
Osteoporosis, Postmenopausal, Susceptibility 54
Osteoporosis Postmenopausal 52
Involutional Osteoporosis 71
Osteoporosis, Senile 69
Senile Osteoporosis 71
Osteop 71

Characteristics:

OMIM:

54
Inheritance:
autosomal dominant


HPO:

32
osteoporosis:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 54 166710
Disease Ontology 12 DOID:11476
ICD10 33 M81.0 M80.0
ICD9CM 35 733.0 733.00
NCIt 47 C3298
SNOMED-CT via HPO 65 263681008 64859006
UMLS 69 C0029456

Summaries for Osteoporosis

MedlinePlus : 41 osteoporosis is a disease that thins and weakens the bones. your bones become fragile and break easily, especially the bones in the hip, spine, and wrist. in the united states, millions of people either already have osteoporosis or are at high risk due to low bone mass. anyone can develop osteoporosis, but it is more common in older women. risk factors include getting older being small and thin having a family history of osteoporosis taking certain medicines being a white or asian woman having low bone density osteoporosis is a silent disease. you might not know you have it until you break a bone. a bone mineral density test is the best way to check your bone health. to keep bones strong, eat a diet rich in calcium and vitamin d, exercise, and do not smoke. if needed, medicines can also help. it is also important to try to avoid falling down. falls are the number one cause of fractures in older adults. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary : Osteoporosis, also known as osteoporosis, postmenopausal, is related to idiopathic juvenile osteoporosis and osteoporosis-pseudoglioma syndrome, and has symptoms including angina pectoris, back pain and muscle cramp. An important gene associated with Osteoporosis is COL1A2 (Collagen Type I Alpha 2 Chain). The drugs Alendronate and Etidronic acid have been mentioned in the context of this disorder. Affiliated tissues include Bone and Bone.

Disease Ontology : 12 A bone resorption disease characterized by decreased density of normally mineralized bone which results_in the thinning of bone tissue and decreased mechanical strength.

UniProtKB/Swiss-Prot : 71 Osteoporosis: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs.

Wikipedia : 72 Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. It is the... more...

Description from OMIM: 166710

Related Diseases for Osteoporosis

Diseases in the Osteoporosis family:

Osteoporosis, Early-Onset Autosomal Dominant Juvenile Primary Osteoporosis

Diseases related to Osteoporosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 328)
id Related Disease Score Top Affiliating Genes
1 idiopathic juvenile osteoporosis 12.4
2 osteoporosis-pseudoglioma syndrome 12.4
3 glucocorticoid-induced osteoporosis 12.2
4 nephrolithiasis/osteoporosis, hypophosphatemic, 2 12.1
5 nephrolithiasis/osteoporosis, hypophosphatemic, 1 12.1
6 juvenile primary osteoporosis 12.0
7 osteoporosis and oculocutaneous hypopigmentation syndrome 12.0
8 bone mineral density qtl18, osteoporosis 11.9
9 osteoporosis, early-onset autosomal dominant 11.8
10 bone mineral density qtl 12, osteoporosis 11.7
11 hajdu-cheney syndrome 11.7
12 macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 11.7
13 amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis and acidosis 11.7
14 dominant hypophosphatemia with nephrolithiasis or osteoporosis 11.7
15 osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome 11.7
16 cutis laxa osteoporosis 11.7
17 acroosteolysis dominant type 11.3
18 werner syndrome 11.1
19 lysinuric protein intolerance 11.0
20 rickets 11.0
21 bone fracture 11.0
22 anorexia nervosa 10.9
23 cerebrotendinous xanthomatosis 10.9
24 severe congenital neutropenia 10.9
25 osteopetrosis 10.9
26 homocystinuria 10.9
27 mental retardation, x-linked, snyder-robinson type 10.9
28 wolcott-rallison syndrome 10.8
29 pituitary adenoma, acth-secreting 10.8
30 multicentric osteolysis, nodulosis, and arthropathy 10.8
31 winchester syndrome 10.8
32 premature aging okamoto type 10.7
33 pigmented nodular adrenocortical disease, primary, 4 10.7
34 dyskeratosis congenita, autosomal recessive 1 10.7
35 aromatase deficiency 10.7
36 dyskeratosis congenita, autosomal recessive 5 10.7
37 osteogenesis imperfecta, type xii 10.7
38 hyaline fibromatosis syndrome 10.7
39 osteogenesis imperfecta, type xiii 10.7
40 dyskeratosis congenita, autosomal dominant 2 10.7
41 hyperparathyroidism 3 10.6
42 stuve-wiedemann syndrome/schwartz-jampel type 2 syndrome 10.6
43 pigmented nodular adrenocortical disease, primary, 3 10.6
44 thrombocytopenia 6 10.6
45 nestor-guillermo progeria syndrome 10.6
46 acth-independent macronodular adrenal hyperplasia 10.6
47 singleton-merten syndrome 1 10.6
48 prader-willi habitus, osteopenia, and camptodactyly 10.6
49 pigmented nodular adrenocortical disease, primary, 2 10.6
50 dyskeratosis congenita, autosomal recessive 2 10.6

Comorbidity relations with Osteoporosis via Phenotypic Disease Network (PDN): (show top 50) (show all 85)


Active Peptic Ulcer Disease Acute Cor Pulmonale
Acute Cystitis Alzheimer Disease
Anxiety Disorder Aortic Atherosclerosis
Aplastic Anemia Asthma Susceptibility, Phf11-Related
Benign Essential Hypertension Bronchiectasis
Bronchitis Bronchopneumonia
Cerebral Atherosclerosis Cerebral Degeneration
Cerebrovascular Disease Chronic Myocardial Ischemia
Chronic Pulmonary Heart Disease Chylomicron Retention Disease
Conjunctivitis Crohn's Disease
Cystitis Decubitus Ulcer
Deficiency Anemia Dermatomycosis
Dyskinesia of Esophagus Dysthymic Disorder
Esophagitis Femoral Vein Thrombophlebitis
Gastroesophageal Reflux Generalized Anxiety Disorder
Generalized Atherosclerosis Heart Disease
Hyperparathyroidism Hypertension, Essential
Hyperuricemia, Pulmonary Hypertension, Renal Failure, and Alkalosis Hypothyroidism
Idiopathic Interstitial Pneumonia Idiopathic Juvenile Osteoporosis
Intervertebral Disc Disease Intestinal Obstruction
Iron Deficiency Anemia Irritable Bowel Syndrome
Left Ventricular Outflow Tract Obstruction Macular Degeneration, Age-Related, 1
Marasmus Monoclonal Paraproteinemia
Neurogenic Bladder Nutritional Deficiency Disease
Opiate Dependence Oral Candidiasis

Graphical network of the top 20 diseases related to Osteoporosis:



Diseases related to Osteoporosis

Symptoms & Phenotypes for Osteoporosis

Symptoms via clinical synopsis from OMIM:

54

Skel:
postmenopausal osteoporosis


Clinical features from OMIM:

166710

Human phenotypes related to Osteoporosis:

32
id Description HPO Frequency HPO Source Accession
1 osteoporosis 32 HP:0000939

UMLS symptoms related to Osteoporosis:


angina pectoris, back pain, muscle cramp, pelvic pain, sciatica, tremor, equilibration disorder

Drugs & Therapeutics for Osteoporosis

Drugs for Osteoporosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 625)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Alendronate Approved Phase 4,Phase 2,Phase 3,Phase 1 121268-17-5, 66376-36-1 2088
2
Etidronic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 7414-83-7, 2809-21-4 3305
3
Teriparatide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 52232-67-4 16133850
4
Calcium Carbonate Approved Phase 4,Phase 3,Phase 2,Phase 1 471-34-1
5
Denosumab Approved Phase 4,Phase 3,Phase 2,Phase 1 615258-40-7
6
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-28-2 5757
7
Medroxyprogesterone acetate Approved, Investigational Phase 4,Phase 3,Phase 1 71-58-9
8
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2 57-83-0 5994
9
Zoledronic acid Approved Phase 4,Phase 3,Phase 2 118072-93-8 68740
10
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
11
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
12
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3 128794-94-5 5281078
13
Mycophenolic acid Approved Phase 4,Phase 3 24280-93-1 446541
14
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
15
Tacrolimus Approved, Investigational Phase 4,Phase 3 104987-11-3 445643 439492
16
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2 112809-51-5 3902
17
Prednisone Approved, Vet_approved Phase 4,Phase 3 53-03-2 5865
18
Anastrozole Approved, Investigational Phase 4,Phase 3,Phase 2 120511-73-1 2187
19
Methyltestosterone Approved Phase 4,Phase 2,Phase 3 58-18-4 6010
20
Testosterone Approved, Investigational Phase 4,Phase 2,Phase 3 58-22-0 6013
21
Benzocaine Approved Phase 4,Phase 3,Early Phase 1 1994-09-7, 94-09-7 2337
22
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
23
Menthol Approved Phase 4,Early Phase 1 2216-51-5 16666
24 Strontium ranelate Approved Phase 4,Phase 2 135459-87-9
25
Demeclocycline Approved Phase 4,Phase 2 127-33-3 5311063
26
Tetracycline Approved, Vet_approved Phase 4,Phase 2 60-54-8 5353990
27
Tibolone Approved Phase 4,Phase 3,Phase 2 5630-53-5
28
Bazedoxifene Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 198481-32-2
29
Esomeprazole Approved, Investigational Phase 4,Phase 1 161796-78-7, 119141-88-7 4594 9579578
30
Acetaminophen Approved Phase 4,Phase 3,Phase 1 103-90-2 1983
31
Fluvastatin Approved Phase 4 93957-54-1 1548972
32
Pamidronate Approved Phase 4,Phase 2,Phase 1 40391-99-9 4674
33
Potassium Citrate Approved, Vet_approved Phase 4,Phase 3
34
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
35
Gliclazide Approved Phase 4 21187-98-4 3475
36
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
37
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
38
Budesonide Approved Phase 4 51333-22-3 63006 5281004
39
Montelukast Approved Phase 4 158966-92-8 5281040
40
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
41
Topiramate Approved Phase 4 97240-79-4 5284627
42
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
43
Salmon Calcitonin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 47931-85-1 16129616
44
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
45
Lopinavir Approved Phase 4 192725-17-0 92727
46
Ritonavir Approved, Investigational Phase 4,Phase 3 155213-67-5 392622
47
Azathioprine Approved Phase 4 446-86-6 2265
48
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 124-94-7 31307
49
Ethanol Approved Phase 4 64-17-5 702
50
Abacavir Approved, Investigational Phase 4,Phase 3 136470-78-5 65140 441300

Interventional clinical trials:

(show top 50) (show all 1696)

id Name Status NCT ID Phase Drugs
1 Osteoporosis and Dental Implant Unknown status NCT00727493 Phase 4 alendronate once weekly 70mg;placebo
2 Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis Unknown status NCT01675297 Phase 4 Risedronate/Cholecalciferol combination;Risedronate
3 Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo Unknown status NCT01945788 Phase 4 Teriparatide (rDNA origin)
4 To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women Unknown status NCT01904110 Phase 4 Risedronate/Cholecalciferol combination(montly);Risedronate/Cholecalciferol combination(weekly)
5 The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels Unknown status NCT01765010 Phase 4 Calcitriol;Alfacalcidol;Cholecalciferol;Placebo
6 Analgesic Effects of the Gastrolith, in Osteoporotic Patients Suffering From Recent Skeletal Pain Caused by Vertebral Fractures Unknown status NCT01482858 Phase 4
7 Effects of Omega-3 Fatty Acids on Bone and Frailty Unknown status NCT00634686 Phase 4
8 Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women Unknown status NCT01926158 Phase 4 Denosumb;Placebo (for denosumab)
9 Multi-centre Clinical Trial on Hormone Replacement Treatment in China Unknown status NCT01698164 Phase 4 estradiol plus MPA;Ximingting Tablet;estradiol plus progesterone
10 The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion Unknown status NCT01310465 Phase 4 zoledronic acid;sodium chloride
11 The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study Unknown status NCT01323608 Phase 4 Vitamin D3;Placebo
12 Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis Unknown status NCT02484508 Phase 4 Guli capsule;Kangguzengsheng capsule
13 Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen Unknown status NCT01560572 Phase 4 tacrolimus OD, mycophenolic acid, prednisolone
14 Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) Unknown status NCT01908556 Phase 4 Letrozole
15 Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? Unknown status NCT00299572 Phase 4 alendronate (Fosamax)
16 A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids Unknown status NCT00273559 Phase 4 prednisone
17 Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors Unknown status NCT00111241 Phase 4 aromatase inhibitors (letrozole, anastrozole)
18 Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis Completed NCT01544894 Phase 4 Raloxifene;Strontium ranelate
19 Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate Completed NCT00327990 Phase 4 Ibandronate;Alendronate
20 Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM) Completed NCT00479037 Phase 4 Full Length Parathyroid Hormone, PTH(1-84);Strontium Ranelate
21 Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window? Completed NCT01166958 Phase 4 Teriparatide;Raloxifene
22 ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. Completed NCT00545090 Phase 4 ibandronate [Bonviva/Boniva]
23 Teriparatide Treatment in Patients With Inherited Osteoporosis Completed NCT01360424 Phase 4 Teriparatide
24 Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use Completed NCT00221299 Phase 4 Risedronate;Parathyroid Hormone
25 Danish Osteoporosis Prevention Study Completed NCT00252408 Phase 4 Hormone replacement therapy
26 Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis Completed NCT01465568 Phase 4 Denosumab;bisphosphonates
27 A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) Completed NCT00545363 Phase 4 Ibandronate
28 STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES) Completed NCT00583518 Phase 4 Parathyroid hormone (PTH)
29 HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids. Completed NCT00376662 Phase 4 Hormone Replacement Therapy and Etidronate
30 The Prevalence of Osteoporosis in Hemodialysis Patients Completed NCT00308828 Phase 4
31 High Dosage Vitamin D and Osteoporosis Completed NCT00491920 Phase 4 cholecalciferol (Vitamin D3);placebo
32 Prevention of Osteoporosis in Breast Cancer Survivors Completed NCT00567606 Phase 4
33 Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis Completed NCT00405392 Phase 4 Ibandronate (SB743830HD)
34 A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women Completed NCT00860964 Phase 4 Placebo;estradiol valerate
35 Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis Completed NCT01753856 Phase 4 Teriparatide;Denosumab;Demeclocycline;Tetracycline;Calcium Supplement;Vitamin D
36 A Study of Teriparatide in Japanese Osteoporosis Patients Completed NCT01430104 Phase 4 Teriparatide;Aspara-CA 600 mg;Alfarol 1.0 µg
37 Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis Completed NCT00259298 Phase 4 teriparatide
38 A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia Completed NCT02604836 Phase 4 Ibandronate
39 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis Completed NCT00191425 Phase 4 Teriparatide;Raloxifene
40 A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. Completed NCT00545051 Phase 4 Placebo;ibandronate
41 A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo Completed NCT00148915 Phase 4 ibandronate;Placebo
42 A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis Completed NCT02598440 Phase 4 Alendronate;Ibandronate
43 BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis Completed NCT00545909 Phase 4 ibandronate [Bonviva/Boniva];ibandronate [Bonviva/Boniva]
44 A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis Completed NCT02598934 Phase 4 Ibandronate
45 A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) Completed NCT00303485 Phase 4 Placebo;Vitamin D and calcium supplementation;ibandronate [Bonviva/Boniva]
46 Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) Completed NCT00271713 Phase 4 ibandronate, calcium and vitamin D;placebo,calcium and vitamin D
47 SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. Completed NCT00545480 Phase 4 ibandronate [Bonviva/Boniva];ibandronate [Bonviva/Boniva]
48 A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment Completed NCT00551174 Phase 4 ibandronate [Bonviva/Boniva];ibandronate [Bonviva/Boniva]
49 A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva Completed NCT00081653 Phase 4 ibandronate [Bonviva/Boniva];ibandronate [Bonviva/Boniva]
50 PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia Completed NCT02598453 Phase 4 Ibandronate

Search NIH Clinical Center for Osteoporosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Osteoporosis cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Osteoporosis:
PREOB

Cochrane evidence based reviews: osteoporosis

Genetic Tests for Osteoporosis

Genetic tests related to Osteoporosis:

id Genetic test Affiliating Genes
1 Postmenopausal Osteoporosis 29
2 Osteoporosis 24 VDR

Anatomical Context for Osteoporosis

MalaCards organs/tissues related to Osteoporosis:

39
Bone, Prostate, Spinal Cord, Testes, Kidney, Bone Marrow, Liver
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Osteoporosis:
id Tissue Anatomical CompartmentCell Relevance
1 Bone Bone Marrow Mononucleated Osteoclasts Affected by disease
2 Bone Bone Marrow Multinucleated Osteoclasts Affected by disease
3 Blood Hematopoietic Bone Marrow Osteoclast Precursor Cells Affected by disease

Publications for Osteoporosis

Articles related to Osteoporosis:

(show top 50) (show all 2546)
id Title Authors Year
1
Content Validity of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis. ( 28083636 )
2017
2
The Prevalence and Risk Factors of Osteoporosis among a Saudi Female Diabetic Population. ( 28507624 )
2017
3
Recent advances in the management of osteoporosis. ( 28529724 )
2017
4
Prevalence of and factors associated with adopting bone health promoting behaviours among people with osteoporosis in Taiwan: a cross-sectional study. ( 28951404 )
2017
5
Depression and Osteoporosis: A Study of 100 Patients. ( 28534600 )
2017
6
OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS. ( 28065194 )
2017
7
Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control. ( 28936581 )
2017
8
Women's Health: Polycystic Ovarian Syndrome, Menopause, and Osteoporosis. ( 28501236 )
2017
9
The osteogenesis-promoting effects of alpha-lipoic acid against glucocorticoid-induced osteoporosis through the NOX4, NF-kappaB, JNK and PI3K/AKT pathways. ( 28611356 )
2017
10
Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine. ( 28878388 )
2017
11
Effects of acupuncture on quality of life and pain in patients with osteoporosis-a pilot randomized controlled trial: reply to comments by Moran et al. ( 28074449 )
2017
12
TNF-I+ Promotes Osteoclastogenesis through JNK Signaling-Dependent Induction of Semaphorin3D Expression in Estrogen-Deficiency Induced Osteoporosis. ( 28059444 )
2017
13
The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation. ( 28936598 )
2017
14
Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria. ( 28821635 )
2017
15
Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women. ( 28523260 )
2017
16
Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis. ( 28512501 )
2017
17
Osteoporosis in Stickler syndrome. A new family case with bone histology study. ( 28159459 )
2017
18
LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia. ( 28111184 )
2017
19
Comment on 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. ( 28941168 )
2017
20
Effects of Recombinant Human Growth Hormone for Osteoporosis: Systematic Review and Meta-Analysis. ( 28069090 )
2017
21
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis. ( 27743017 )
2017
22
Reduced prealbumin is associated with bone mineral density in women with osteoporosis. ( 27727007 )
2017
23
Advances in treatment of glucocorticoid-induced osteoporosis. ( 28857847 )
2017
24
Evaluation of Correlation between Salivary Calcium, Alkaline Phosphatase and Osteoporosis- A Prospective, Comparative and Observational Study. ( 28511512 )
2017
25
New molecules modulating bone metabolism - new perspectives in the treatment of osteoporosis. ( 28948818 )
2017
26
Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients. ( 28522769 )
2017
27
Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model. ( 28928654 )
2017
28
A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis. ( 27679514 )
2017
29
Type 2 diabetes and osteoporosis: a guide to optimal management. ( 28938433 )
2017
30
Variable Expressivity and Response to Bisphosphonate Therapy in a Family with Osteoporosis Pseudoglioma Syndrome. ( 28891484 )
2017
31
Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project. ( 28695555 )
2017
32
Association between primary biliary cholangitis and osteoporosis: meta-analysis. ( 28948408 )
2017
33
SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. ( 28937996 )
2017
34
Denosumab treatment in postmenopausal women with osteoporosis. ( 28938991 )
2017
35
Greater Intake of Fruit and Vegetables Is Associated with Greater Bone Mineral Density and Lower Osteoporosis Risk in Middle-Aged and Elderly Adults. ( 28045945 )
2017
36
How frequent is osteogenesis imperfecta in patients with idiopathic osteoporosis?: Case reports. ( 28858097 )
2017
37
Osteoporosis-pseudoglioma syndrome: Report of two cases and a manifesting carrier. ( 28145787 )
2017
38
Vitamin D and osteoporosis in chronic kidney disease. ( 28940158 )
2017
39
Effect of intervention initiation timing of pulsed electromagnetic field on ovariectomy-induced osteoporosis in rats. ( 28510268 )
2017
40
Denosumab treatment in postmenopausal women with osteoporosis. ( 28938992 )
2017
41
The Role of Dietary Compounds in the Therapy of Nicotine-Induced Osteoporosis. ( 28950810 )
2017
42
Quantitative Ultrasound of the Mandible as a Novel Screening Approach for Osteoporosis. ( 28943183 )
2017
43
Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis. ( 28128304 )
2017
44
Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2A years. ( 28058444 )
2017
45
Femoral osteoporosis is more common than lumbar osteoporosis in patients with Werner syndrome. ( 28508498 )
2017
46
Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice. ( 28501578 )
2017
47
Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study. ( 27732335 )
2017
48
Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats. ( 27917698 )
2017
49
Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area. ( 28331966 )
2017
50
Transplantation of HGF modified Dental Pulp Stem Cells Prevents Bone Loss in the Early Phase of Ovariectomy-induced Osteoporosis. ( 28950723 )
2017